METHOD OF PURIFYING WHOLE VIRUS PARTICLES

Development of methods for production of a whole virus vaccine candidate stock and novel adaptive mutations in hepatitis C virus

Substituted nucleosides, nucleotides and analogs thereof

Modified Hepatitis C virus proteins

Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1)

Chimeric GB virus B (GBV-B)

Method for inducing complete hepatitis c virus (hcv) replication in vitro

Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA